SPECIAL NOTICE
Q -- Pharmacy Benefit Management Services
- Notice Date
- 2/1/2022 11:35:20 AM
- Notice Type
- Special Notice
- NAICS
- 524114
— Direct Health and Medical Insurance Carriers
- Contracting Office
- DEFENSE HEALTH AGENCY (DHA)
- ZIP Code
- 00000
- Response Due
- 2/11/2022 10:59:00 AM
- Point of Contact
- Viktoria Reed, Phone: 3036763648, Fax: 3036763554, Dwight Bonham, Phone: 3036763731, Fax: 3036763554
- E-Mail Address
-
viktoria.s.reed.civ@mail.mil, dwight.bonham.civ@mail.mil
(viktoria.s.reed.civ@mail.mil, dwight.bonham.civ@mail.mil)
- Description
- THIS IS A NOTICE OF INTENT, NOT A REQUSET FOR PROPOSAL. A SOLICITATION DOCUMENT WILL NOT BE ISSUED AND PROPOSALS WILL NOT BE REQUESTED. The Defense Health Agency (DHA), Managed Care � Contract Division (MC-CD) intends to issue a sole-source bridge action to extend the TRICARE Pharmacy 4th Generation (TPharm4) contract (HT9402-14-D-0002) with Express Scripts Inc. (ESI), in accordance with Federal Acquisition Regulation (FAR) 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements. The bridge action period of performance will be from November 1, 2022, through December 31, 2022 with two (2) 1-month options. The bridge action to extend performance is necessary to ensure continued support to the Defense Health Agency (DHA) by continuing to meet critical requirements, to prevent a gap in service of pharmacy benefits to all eligible beneficiaries from the end of the current TPharm4 contract on October 31, 2022 until the competitively awarded follow-on contract (TPharm5) full performance begins on January 1, 2023 and to ensure full performance of the new National Prime Vendor Pharmaceutical contract, awarded by the Defenses Logistics Agency (DLA), has begun. The TPharm4 contract, as required under Federal Statue U.S.C � 1074g, provides Pharmacy Benefit Management (PBM) services for the Military Health System (MHS) by providing access to prescription medications through a retail pharmacy network, dispensing prescriptions at the mail order pharmacy (MOP), and adjudicating Military Treatment Facility (MTF) prescriptions using a central patient profile reflecting transactions at all points of service. This is not a solicitation for competitive proposals; however, if any interested party believes that they can meet the above requirement, they may submit a capability statement to the point of contact listed in the Special Notice. All information furnished must be in writing and must contain sufficient detail to allow DHA to be able to determine if the interested party can perform the requirement described herein. The Government will consider responses received by the established due date/time set forth in this notice. If no affirmative written responses are received by 11:59 PM on 11 February 2022, bridge action will be processed without further notice. Any questions regarding this notice must be submitted in writing via email to the point of contact. A determination by the Government not to compete this requirement is solely within the discretion of the Government.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/a45d2420741440dd810d6566cb84c0b7/view)
- Place of Performance
- Address: USA
- Country: USA
- Country: USA
- Record
- SN06229547-F 20220203/220201230109 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |